603456 reported revenue of ¥2.58B for the period ended 2026-06-30, -10.3% year on year. Net income was ¥0.38B, a 14.8% net margin on a 36.9% gross margin. The largest revenue line is 新药定制研发和生产服务(CDMO) at 77% of the total. Free cash flow for the period was ¥0.34B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.58B | -10.3% |
| Gross profit | ¥0.95B | — |
| Operating income | ¥0.49B | — |
| Net income | ¥0.38B | -27.7% |
| Gross margin | 36.9% | Net margin 14.8% |
| Revenue Q/Q | +14.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 新药定制研发和生产服务(CDMO) | ¥1.97B | 76.6% |
| 特色原料药及中间体 | ¥0.51B | 20.0% |
| 其他 | ¥0.09B | 3.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.63B | 63.1% |
| R&D | ¥0.13B | 5.0% |
| SG&A | ¥0.26B | 10.1% |
| Tax & other | ¥0.11B | 4.1% |
| Item | Amount |
|---|---|
| Operating cash flow | ¥0.42B |
| Capital expenditure | ¥0.08B |
| Free cash flow | ¥0.34B |
| Cash conversion (OCF / net income) | 145% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万科A ・ 中兴通讯 ・ TCL科技 ・ 中联重科 ・ 申万宏源 ・ 东方盛虹 ・ 美的集团 ・ 潍柴动力 ・ 藏格矿业 ・ 徐工机械 ・ 云南白药 ・ 泸州老窖
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies